|
1
|
Hungness ES, Safa M, Shaughnessy EA, Aron
BS, Gazder PA, Hawkins HH, Lower EE, Seeskin C, Yassin RS and
Hasselgren PO: Bilateral synchronous breast cancer: Mode of
detection and comparison of histologic features between the 2
breasts. Surgery. 128:702–707. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hartman M, Czene K, Reilly M, Adolfsson J,
Bergh J, Adami H-O, Dickman PW and Hall P: Incidence and prognosis
of synchronous and metachronous bilateral breast cancer. J Clin
Oncol. 25:4210–4216. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
MacGrogan G, Tot T, Rakha E and Morrow M:
Bilateral breast carcinoma and nonsynchronous breast carcinomaWHO
Classification of Tumours of the Breast. Lakhani SR, Ellis OI,
Schnitt SJ, Tan PH and van de Vijver MJ: 4. 4th edition. IARC;
Lyon: pp. 69–70. 2012
|
|
4
|
Huo D, Melkonian S, Rathouz PJ, Khramtsov
A and Olopade OI: Concordance in histological and biological
parameters between first and second primary breast cancers. Cancer.
117:907–915. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holm M, Tjønneland A, Balslev E and Kroman
N: Prognosis of synchronous bilateral breast cancer: A review and
meta-analysis of observational studies. Breast Cancer Res Treat.
146:461–475. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brennan ME, Houssami N, Lord S, Macaskill
P, Irwig L, Dixon JM, Warren RM and Ciatto S: Magnetic resonance
imaging screening of the contralateral breast in women with newly
diagnosed breast cancer: Systematic review and meta-analysis of
incremental cancer detection and impact on surgical management. J
Clin Oncol. 27:5640–5649. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Senkus E, Szade J, Pieczyńska B, Zaczek A,
Pikiel J, Sosińska-Mielcarek K, Karpińska A and Jassem J: Are
synchronous and metachronous bilateral breast cancers different? An
immunohistochemical analysis aimed at intrinsic tumor phenotype.
Int J Clin Exp Pathol. 7:353–363. 2013.PubMed/NCBI
|
|
8
|
Chen Y, Thompson W, Semenciw R and Mao Y:
Epidemiology of contralateral breast cancer. Cancer Epidemiol
Biomarkers Prev. 8:855–861. 1999.PubMed/NCBI
|
|
9
|
Singletary SE: Rating the risk factors for
breast cancer. Ann Surg. 237:474–482. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Adami H-O, Hansen J, Jung B and Rimsten A:
Characteristics of familial breast cancer in Sweden: Absence of
relation to age and unilateral versus bilateral disease. Cancer.
48:1688–1695. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Polednak AP: Bilateral synchronous breast
cancer: A population-based study of characteristics, method of
detection, and survival. Surgery. 133:383–389. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jobsen JJ, van der Palen J, Ong F,
Riemersma S and Struikmans H: Bilateral breast cancer, synchronous
and metachronous; differences and outcome. Breast Cancer Res Treat.
153:277–283. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song F, Li X, Song F, Zhao Y, Li H, Zheng
H, Gao Z, Wang J, Zhang W and Chen K: Comparative genomic analysis
reveals bilateral breast cancers are genetically independent.
Oncotarget. 6:31820–31829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fountzilas E, Kotoula V, Zagouri F,
Giannoulatou E, Kouvatseas G, Pentheroudakis G, Koletsa T, Bobos M,
Papadopoulou K, Samantas E, et al: Disease evolution and
heterogeneity in bilateral breast cancer. Am J Cancer Res.
6:2611–2630. 2016.PubMed/NCBI
|
|
15
|
Persson M, Andrén Y, Moskaluk CA, Frierson
HF Jr, Cooke SL, Futreal PA, Kling T, Nelander S, Nordkvist A,
Persson F and Stenman G: Clinically significant copy number
alterations and complex rearrangements of MYBNFIB in head and neck
adenoid cystic carcinoma. Genes Chromosomes Cancer. 51:805–817.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jee KJ, Persson M, Heikinheimo K,
Passador-Santos F, Aro K, Knuutila S, Odell EW, Mäkitie A, Sundelin
K, Stenman G and Leivo I: Genomic profiles and CRTC1-MAML2 fusion
distinguish different subtypes of mucoepidermoid carcinoma. Mod
Pathol. 26:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Persson M, Andrén Y, Mark J, Horlings HM,
Persson F and Stenman G: Recurrent fusion of MYBNFIB transcription
factor genes in carcinomas of the breast and head and neck. Proc
Natl Acad Sci USA. 106:18740–18744. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Andersson MK and Stenman G: The landscape
of gene fusions and somatic mutations in salivary gland neoplasms -
Implications for diagnosis and therapy. Oral Oncol. 57:63–69. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fehr A, Kovács A, Löning T, Frierson H Jr,
van den Oord J and Stenman G: The MYB-NFIB gene fusion-a novel
genetic link between adenoid cystic carcinoma and dermal
cylindroma. J Pathol. 224:322–327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ho AS, Kannan K, Roy DM, Morris LG, Ganly
I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, et al: The
mutational landscape of adenoid cystic carcinoma. Nat Genet.
45:791–798. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martelotto LG, De Filippo MR, Ng CK,
Natrajan R, Fuhrmann L, Cyrta J, Piscuoglio S, Wen HC, Lim RS, Shen
R, et al: Genomic landscape of adenoid cystic carcinoma of the
breast. J Pathol. 237:179–189. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stenman G, Sandros J, Dahlenfors R,
Juberg-Ode M and Mark J: 6q- and loss of the Y chromosome - two
common deviations in malignant human salivary gland tumors. Cancer
Genet Cytogenet. 22:283–293. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nordkvist A, Mark J, Gustafsson H, Bang G
and Stenman G: Non-random chromosome rearrangements in adenoid
cystic carcinoma of the salivary glands. Genes Chromosomes Cancer.
10:115–121. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brayer KJ, Frerich CA, Kang H and Ness SA:
Recurrent fusions in MYBMYBL1 define a common, transcription
factor-driven oncogenic pathway in salivary gland adenoid cystic
carcinoma. Cancer Discov. 6:176–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Drier Y, Cotton MJ, Williamson KE,
Gillespie SM, Ryan RJ, Kluk MJ, Carey CD, Rodig SJ, Sholl LM,
Afrogheh AH, et al: An oncogenic MYB feedback loop drives alternate
cell fates in adenoid cystic carcinoma. Nat Genet. 48:265–272.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brill LB II, Kanner WA, Fehr A, Andrén Y,
Moskaluk CA, Löning T, Stenman G and Frierson HF Jr: Analysis of
MYB expression and MYB-NFIB gene fusions in adenoid cystic
carcinoma and other salivary neoplasms. Mod Pathol. 24:1169–1176.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wetterskog D, Lopez-Garcia MA, Lambros MB,
A'Hern R, Geyer FC, Milanezi F, Cabral MC, Natrajan R, Gauthier A,
Shiu K, et al: Adenoid cystic carcinomas constitute a genomically
distinct subgroup of triple-negative and basal-like breast cancers.
J Pathol. 226:84–96. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wetterskog D, Wilkerson PM, Rodrigues DN,
Lambros MB, Fritchie K, Andersson MK, Natrajan R, Gauthier A, Di
Palma S, Shousha S, et al: Mutation profiling of adenoid cystic
carcinomas from multiple anatomical sites identifies mutations in
the RAS pathway, but no KIT mutations. Histopathology. 62:543–550.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sapino A, Sneige N and Eusebi V: Adenoid
cystic carcinomaWHO Classification of Tumours of the Breast.
Lakhani SR, Ellis OI, Schnitt SJ, Tan PH and van de Vijver MJ: 4.
4th edition. IARC; Lyon: pp. 56–57. 2012
|
|
30
|
Foschini MP, Morandi L, Asioli S, Giove G,
Corradini AG and Eusebi V: The morphological spectrum of salivary
gland type tumours of the breast. Pathology. 49:215–227. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stenman G, Licitra L, Said-Al-Naief N, van
Zante A and Yarbrough WG: Adenoid cystic carcinomaWHO
Classification of Head and Neck Tumours. 9. 4th edition. El-Naggar
AK, Chan JKC, Grandis JR, Takata T and Slootweg PJ: IARC; Lyon: pp.
164–165. 2017
|
|
32
|
Hungermann D, Schmidt H, Natrajan R, Tidow
N, Poos K, Reis-Filho JS, Brandt B, Buerger H and Korsching E:
Influence of whole arm loss of chromosome 16q on gene expression
patterns in oestrogen receptor-positive, invasive breast cancer. J
Pathol. 224:517–528. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stacher E, Boldt V, Leibl S, Halbwedl I,
Popper HH, Ullmann R, Tavassoli FA and Moinfar F: Chromosomal
aberrations as detected by array comparative genomic hybridization
in early low-grade intraepithelial neoplasias of the breast.
Histopathology. 59:549–555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lakhani SR, Rakha E and Simpson PT: WHO
Classification of Tumours of the Breast. Lakhani SR, Ellis OI,
Schnitt SJ, Tan PH and van de Vijver MJ: 4. 4th edition. IARC;
Lyon: pp. 40–42. 2012
|
|
35
|
Stenman G, Andersson MK and Andrén Y: New
tricks from an old oncogene: Gene fusion and copy number
alterations of MYB in human cancer. Cell Cycle. 9:2986–2995. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tse GMK, Kung FYL, Chan ABW, Law BKB,
Chang AR and Lo K-W: Clonal analysis of bilateral mammary
carcinomas by clinical evaluation and partial allelotyping. Am J
Clin Pathol. 120:168–174. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saad RS, Denning KL, Finkelstein SD, Liu
Y, Pereira TC, Lin X and Silverman JF: Diagnostic and prognostic
utility of molecular markers in synchronous bilateral breast
carcinoma. Mod Pathol. 21:1200–1207. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Di Bonito M, Cantile M, Cerrone M, Liguori
G and Botti G: Synchronous pleomorphic adenoma and invasive ductal
carcinoma in distinct breasts. Breast J. 21:428–430. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Da Silva L, Buck L, Simpson PT, Reid L,
McCallum N, Madigan BJ and Lakhani SR: Molecular and morphological
analysis of adenoid cystic carcinoma of the breast with synchronous
tubular adenosis. Virchows Arch. 454:107–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
